The size of the head and neck cancer diagnostics market in North America is expected to grow at a significant growth rate of 11.35% CAGR during the forecast period.
While Head and Neck cancer is rated to be among the top ten most prevalent types of cancers in the world, it is extensively prevalent in the regions where the consumption of alcohol and of tobacco is high. For the proper cure of cancer, there is a need for early diagnosis of cancer and prompt treatment. With the growing awareness among the individuals, there is an increase in a number of diagnostic procedures for head and neck cancer, particularly pharyngeal and oral cancers, inducing growth in the market.
The head and neck cancer diagnostics market in North America is expected to grow in the future with an increasing number of incidences of the disease. The head and neck cancer are one of the top 6 cancers in the world to affect people. In the United States alone it is estimated to affect close to 55000 people in the year 2014. The market for head and neck cancer in the region includes North, Central, and South America. The US is estimated to have the largest market share in the region and is followed by Brazil Mexico and Canada
A rise in the aging population has also contributed to the increased prevalence of chronic diseases, especially head and neck related cancers, increasing awareness among the individuals towards cancer, and an increase in the people and government expenditure in healthcare. However, Low Adoption Rate of Digital Technology-Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets
This research report on the North America Head and Neck Cancer Diagnostics Market segmented and sub-segmented into the following categories:
Regional Analysis:
North America is currently playing the leading role in the global market and the primary reason for the growth of the market is attributed to the fact that there is a rising demand for diagnostic imaging, new advancements, and innovations in treatment modes, and incorporation of novel technologies in diagnostic equipment.
The growth of the market is further primarily driven by the increasing evolution of the healthcare sector due to the intensification of research and development activities in this industry. Various research institutes and organizations' growing initiatives to improve medical facilities and services further drive the market's growth. The Centres for Disease Control and Prevention, a leading institute of public health in the United States, provided grants for many health care initiatives in the region in 2020. Chronic disease and health promotion have received most of the resources with 51.27% and 12.02%, respectively. This was followed by prevention of HIV / AIDS, viral hepatitis, STIs, and tuberculosis, which received 10.02%, as well as injury prevention and control with 6.16% of funds. . The growing number of health disorders and the increasing demand for better treatments and preventative measures have led to technological advancements in the medical industry.
Some of the Prominent Companies leading the North America Head and Neck Cancer Diagnostics Market Profiled in the Report are Philips Healthcare, GE Healthcare, Varian Siemens Healthcare, Medical Systems, Shimadzu Corporation, Velscope VX, Identafi, and AdDent Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Test type
5.1.1 Diagnostic imaging
5.1.1.1 PET/CT
5.1.1.2 MRI
5.1.1.3 X-ray
5.1.1.4 Barium Swallow test
5.1.2 Biopsy
5.1.2.1 Incisional Biopsy
5.1.2.2 Fine needle aspiration Biopsy
5.1.2.3 HPV testing
5.1.3 Endoscopy
5.1.3.1 Pharyngoscopy
5.1.3.2 Laryngoscopy
5.1.3.3 Panendoscopy
5.1.4 Dental diagnostics
5.1.4.1 Fluorescence Visualization
5.1.4.2 Toluidine blue dye based method
5.1.4.3 Acetic acid rinse method
5.1.4.4 Brush biopsy
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 3M ESPE DENTAL SOLUTIONS
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 BIOMET 3I
8.3 DENTSPLY INTERNATIONAL, INC
8.4 HENRY SCHEIN, INC.
8.5 KERR CORPORATION
8.6 IVOCLAR VIVADENT AG
8.7 NOBEL BIOCARE
8.8 PATTERSON COMPANIES, INC.
8.9 ULTRADENT PRODUCTS
8.10 ZIMMER DENTAL
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
